Browsing by Subject
Ara mostrant els elements 1-2 d 2
-
Dostarlimab: From preclinical investigation to drug approval and future directions
(Taylor & Francis, 2023) -
Surrogate endpoints for early-stage breast cancer: a review of the state of the art, controversies, and future prospects
(SAGE Publications, 2021-01-01)